KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,107 | -20.4% | 18,490 | +2.7% | 0.01% | -22.2% |
| Q2 2023 | $3,902 | +20.3% | 18,000 | 0.0% | 0.01% | +12.5% |
| Q1 2023 | $3,244 | -7.1% | 18,000 | 0.0% | 0.01% | -11.1% |
| Q4 2022 | $3,493 | -99.9% | 18,000 | 0.0% | 0.01% | -25.0% |
| Q3 2022 | $4,084,000 | +62.2% | 18,000 | -10.7% | 0.01% | +71.4% |
| Q2 2022 | $2,518,000 | +112.1% | 20,150 | +108.8% | 0.01% | +133.3% |
| Q1 2022 | $1,187,000 | +2.9% | 9,650 | +10.3% | 0.00% | 0.0% |
| Q4 2021 | $1,154,000 | +14.3% | 8,750 | +2.9% | 0.00% | 0.0% |
| Q3 2021 | $1,010,000 | +6.8% | 8,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $946,000 | -4.7% | 8,500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $993,000 | +14.5% | 8,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $867,000 | +23.3% | 8,500 | -4.5% | 0.00% | 0.0% |
| Q3 2020 | $703,000 | – | 8,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |